Manning & Napier Group LLC Has $6.50 Million Position in Clorox Co (CLX)

Manning & Napier Group LLC increased its position in shares of Clorox Co (NYSE:CLX) by 11.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,209 shares of the company’s stock after purchasing an additional 4,426 shares during the period. Manning & Napier Group LLC’s holdings in Clorox were worth $6,499,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Cornerstone Wealth Management LLC purchased a new position in Clorox during the second quarter worth about $105,000. Ostrum Asset Management acquired a new position in Clorox during the first quarter worth about $112,000. Fort L.P. acquired a new position in Clorox during the second quarter worth about $129,000. Whittier Trust Co. of Nevada Inc. grew its position in Clorox by 1,297.4% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock worth $148,000 after buying an additional 1,505 shares during the period. Finally, IMS Capital Management acquired a new position in Clorox during the second quarter worth about $161,000. 78.36% of the stock is owned by hedge funds and other institutional investors.

CLX stock opened at $144.84 on Friday. The company has a market capitalization of $19.21 billion, a PE ratio of 23.14, a price-to-earnings-growth ratio of 3.11 and a beta of 0.36. Clorox Co has a 12 month low of $113.57 and a 12 month high of $153.38. The company has a current ratio of 1.09, a quick ratio of 0.67 and a debt-to-equity ratio of 3.15.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 2nd. The company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.58 by $0.08. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.72 billion. Clorox had a net margin of 13.44% and a return on equity of 103.18%. The company’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.53 earnings per share. Equities analysts anticipate that Clorox Co will post 6.41 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be given a $0.96 dividend. The ex-dividend date is Tuesday, October 30th. This represents a $3.84 annualized dividend and a dividend yield of 2.65%. Clorox’s dividend payout ratio is presently 61.34%.

Several brokerages have weighed in on CLX. Deutsche Bank lowered shares of Clorox from a “hold” rating to a “sell” rating and set a $123.00 target price on the stock. in a research report on Wednesday. Barclays set a $131.00 target price on shares of Clorox and gave the stock a “hold” rating in a research report on Saturday, October 6th. Zacks Investment Research lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Friday, October 5th. Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research report on Tuesday, September 25th. Finally, ValuEngine upgraded shares of Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $137.21.

In other news, EVP Jon M. Balousek sold 3,354 shares of the stock in a transaction that occurred on Wednesday, August 29th. The shares were sold at an average price of $144.73, for a total value of $485,424.42. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Michael R. Costello sold 9,265 shares of the stock in a transaction that occurred on Monday, August 13th. The shares were sold at an average price of $140.02, for a total transaction of $1,297,285.30. Following the completion of the sale, the senior vice president now owns 34,293 shares in the company, valued at $4,801,705.86. The disclosure for this sale can be found here. Insiders sold 29,268 shares of company stock worth $4,196,686 over the last quarter. Company insiders own 1.00% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: How Do I Invest in Dividend Stocks

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply